KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Net Margin (2016 - 2025)

AbbVie (ABBV) has disclosed Net Margin for 14 consecutive years, with 10.92% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin rose 1107.0% to 10.92% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.92%, a 69.0% decrease, with the full-year FY2025 number at 6.92%, down 69.0% from a year prior.
  • Net Margin was 10.92% for Q4 2025 at AbbVie, up from 1.19% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 33.19% in Q1 2022 to a low of 0.79% in Q1 2023.
  • A 5-year average of 12.92% and a median of 10.87% in 2024 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: soared 2705bps in 2021, then plummeted -3398bps in 2023.
  • AbbVie's Net Margin stood at 27.17% in 2021, then plummeted by -40bps to 16.35% in 2022, then tumbled by -50bps to 8.13% in 2023, then tumbled by -102bps to 0.15% in 2024, then surged by 7271bps to 10.92% in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Net Margin are 10.92% (Q4 2025), 1.19% (Q3 2025), and 6.1% (Q2 2025).